<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00639912</url>
  </required_header>
  <id_info>
    <org_study_id>MAN1374</org_study_id>
    <nct_id>NCT00639912</nct_id>
  </id_info>
  <brief_title>Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.</brief_title>
  <acronym>CINIMA</acronym>
  <official_title>Randomized Trial on the Effects of Hydration With Sodium Chloride Versus Sodium Bicarbonate to Prevent Contrast Induced Nephropathy, in Patients Undergoing Primary Coronary Interventions for Acute ST Elevation Myocardial Infarction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arcispedale Santa Maria Nuova-IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Sanitaria Ospedaliera</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Arcispedale Santa Maria Nuova-IRCCS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to test the efficacy of low versus high volume hydration and two
      different solutions (sodium chloride versus sodium bicarbonate) in preventing contrast
      induced nephropathy (CIN) in ST elevation myocardial infarction (STEMI) patients undergoing
      primary PCI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Contrast-induced nephropathy (CIN) is associated with increased morbidity and mortality after
      percutaneous coronary interventions (PCI). Patients with ST elevation myocardial infarction
      (STEMI) are at high risk for CIN because of hemodynamic instability of the patient, inability
      to prevent the phenomenon (hydration) and the possible exposure to high volume of contrast
      media. Recent reports have shown incidence of CIN up to 19% in this population and a related
      increase of in-hospital mortality.

      Merten e coll. (JAMA 2004) reported that sodium bicarbonate infusion before and after
      contrast exposure in patients with chronic renal failure and without myocardial infarction
      (AMI) is more effective than sodium chloride in preventing CIN.

      Up to date there is no evidence of any effective prophylactic measures in patients with STEMI
      undergoing primary PCI.

      The aim of the study is to test the efficacy of low versus high volume hydration and the
      efficacy of two different solutions (sodium chloride versus sodium bicarbonate) in preventing
      CIN in STEMI patients undergoing primary PCI.

      The infusion of the randomized solution will start just after randomization and after
      determination of baseline serum creatinine.

      Determination of serum creatinine will be repeated at 24, 48 and 72 hours after
      randomization. Creatinine clearance will be calculated with Cockroft-Gault formula and MDRD.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>contrast induced nephropathy incidence</measure>
    <time_frame>24, 48 and 72 hours</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">599</enrollment>
  <condition>Contrast Induced Nephropathy</condition>
  <arm_group>
    <arm_group_label>A: low volume saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Solution of 154 mEq/L of sodium chloride. Rate of infusion: 1 ml/kg/hour for 12 hours after the procedure, starting in the Cath Lab.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B: high volume saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Solution of 154 mEq/L of sodium chloride. Rate of infusion: 3 ml/Kg for 1 hour, followed by 1 ml/Kg/hour for 12 hours after the procedure, starting in the Cath lab.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C: low volume sodium bicarbonate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Solution of 154 mEq/L of sodium bicarbonate. Rate of infusion: 1 ml/Kg/hour for 12 hours after the procedure, starting in the Cath Lab.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>D: high volume sodium bicarbonate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Solution of 154 mEq/L of sodium bicarbonate. Rate of infusion: 3 ml/Kg for 1 hour, followed by 1 ml/Kg/hour for 12 hours after the procedure, starting in the Cath Lab.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium chloride</intervention_name>
    <description>Solution of 154 mEq/L of sodium chloride. Rate of infusion: 1 ml/Kg/hour for 12 hours.</description>
    <arm_group_label>A: low volume saline</arm_group_label>
    <other_name>Normal saline. Isotonic saline. Sodium chloride 0.9% .</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium chloride</intervention_name>
    <description>Solution of 154 mEq/L of sodium chloride. Rate of infusion: 3 ml/Kg for 1 hour, followed by 1 ml/Kg/hour for 12 hours</description>
    <arm_group_label>B: high volume saline</arm_group_label>
    <other_name>Normal saline. Isotonic saline. Sodium Chloride 0.9% .</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium bicarbonate</intervention_name>
    <description>154 mEq/L of sodium bicarbonate in dextrose solution. Rate of infusion: 1 ml/Kg/hour for 12 hours.</description>
    <arm_group_label>C: low volume sodium bicarbonate</arm_group_label>
    <other_name>Addition of 77 ml 8,4% Na bicarbonate to 423 ml 5% dextrose.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium bicarbonate</intervention_name>
    <description>154 mEq/L of sodium chloride in dextrose solution. Rate of infusion: 3 ml/Kg for 1 hour, followed by 1 ml/Kg/hour for 12 hours.</description>
    <arm_group_label>D: high volume sodium bicarbonate</arm_group_label>
    <other_name>Addition of 77 ml 8,4% Na bicarbonate to 423 ml 5% dextrose.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years of years

          -  Chest pain lasting at least 30 minutes, non responsive to nitrates, associated to ST
             elevation of at least 0.2 mV on surface ECG in two or more contiguous leads or to new
             left bundle branch block.

          -  Informed consent

        Exclusion Criteria:

          -  Chronic hemodialytic or peritoneal treatment

          -  Coronary anatomy unsuitable for PCI

          -  Need of emergency coronary artery by-pass grafting

          -  Post-anoxic coma

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Manari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arcispedale S. Maria Nuova Reggio Emilia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria S. Anna</name>
      <address>
        <city>Ferrara</city>
        <state>Emilia-romagna</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nuovo Ospedale Civile di Baggiovara</name>
      <address>
        <city>Modena</city>
        <state>Emilia-Romagna</state>
        <zip>41100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arcispedale S. Maria Nuova</name>
      <address>
        <city>Reggio Emilia</city>
        <state>Emilia-Romagna</state>
        <zip>42100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dipartimento di Cardiologia, Ospedale di Lavagna</name>
      <address>
        <city>Lavagna</city>
        <state>Genova</state>
        <zip>16033</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dipartimento di Cardiologia, Ospedale Maggiore</name>
      <address>
        <city>Parma</city>
        <zip>43100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, Tumlin J; CIN Consensus Working Panel. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006 Sep 18;98(6A):27K-36K. Epub 2006 Feb 23. Review.</citation>
    <PMID>16949378</PMID>
  </results_reference>
  <results_reference>
    <citation>Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004 Nov 2;44(9):1780-5.</citation>
    <PMID>15519007</PMID>
  </results_reference>
  <results_reference>
    <citation>Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006 Jun 29;354(26):2773-82.</citation>
    <PMID>16807414</PMID>
  </results_reference>
  <results_reference>
    <citation>Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004 May 19;291(19):2328-34.</citation>
    <PMID>15150204</PMID>
  </results_reference>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2008</study_first_submitted>
  <study_first_submitted_qc>March 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2008</study_first_posted>
  <last_update_submitted>November 29, 2010</last_update_submitted>
  <last_update_submitted_qc>November 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2010</last_update_posted>
  <responsible_party>
    <name_title>Manari Antonio</name_title>
    <organization>Arcispedale S. Maria Nuova</organization>
  </responsible_party>
  <keyword>contrast induced nephropathy STEMI PCI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

